Syringaresinol-4- O - β - d -glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes

Abstract

Syringaresinol-4-O-β-d-glucoside (SSG), a furofuran-type lignan, was found to modulate lipid and glucose metabolism through an activity screen of lipid accumulation and glucose consumption, and was therefore considered as a promising candidate for the prevention and treatment of metabolic disorder, especially in lipid and glucose metabolic homeostasis. In this study, the effects of SSG on lipogenesis and glucose consumption in HepG2 cells and C2C12 myotubes were further investigated. Treatment with SSG significantly inhibited lipid accumulation by oil red O staining and reduced the intracellular contents of total lipid, cholesterol and triglyceride in HepG2 cells. No effect was observed on cell viability in the MTT assay at concentrations of 0.1–10 μmol/L. SSG also increased glucose consumption by HepG2 cells and glucose uptake by C2C12 myotubes. Furthermore, real-time quantitative PCR revealed that the beneficial effects were associated with the down-regulation of sterol regulatory element-binding proteins-1c, -2 (SREBP-1c, -2), fatty acid synthase (FAS), acetyl CoA carboxylase (ACC) and hydroxyl methylglutaryl CoA reductase (HMGR), and up-regulation of peroxisome proliferator-activated receptors alpha and gamma (PPARα and PPARγ). SSG also significantly elevated transcription activity of PPARγ tested by luciferase assay. These results suggest that SSG is an effective regulator of lipogenesis and glucose consumption and might be a candidate for further research in the prevention and treatment of lipid and glucose metabolic diseases.

Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters

“…Obesity, type 2 diabetes and non-alcohol fatty liver disease are aspects of metabolic syndrome, which is a major public health problem worldwide36., 37., 38., 39., 40.. Thermogenesis is considered a therapeutic target for obesity 41 .…”

Chemical Structure and Biological Activities of Secondary Metabolites from Salicornia europaea L.

“…Compound 63 was found in the stem bark of Albizzia julibrissin [ 121 ], the Thai medicinal plant Capparis flavicans [ 122 ], and leaves from the Fatsia japonica plant [ 123 ]. This compound also has been found to modulate lipid and glucose metabolism in HepG2 cells and C2C12 myotubes ( Table 6 ) [ 124 ].…”

The caffeic acid moiety plays an essential role in attenuating lipid accumulation by chlorogenic acid and its analogues

“…Moreover, a series of cinnamic acid cyclohexanol esters were synthesized to explore the signicance of the phenolic hydroxyl groups in chlorogenic acid and caffeic acid. By the approach of a cell-based bioassay, 26 the regulation of above compounds on oleic acid-elicited lipid accumulation in HepG2 cells and the expression of lipogenic, lipid oxidation-related genes are reported in this paper.…”